{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T09:35:18Z","timestamp":1774690518686,"version":"3.50.1"},"reference-count":187,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vascular Pharmacology"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.vph.2016.07.003","type":"journal-article","created":{"date-parts":[[2016,7,4]],"date-time":"2016-07-04T12:47:36Z","timestamp":1467636456000},"page":"77-86","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":69,"special_numbering":"C","title":["Bone loss and vascular calcification: A bi-directional interplay?"],"prefix":"10.1016","volume":"86","author":[{"given":"Cristina","family":"Vassalle","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annamaria","family":"Mazzone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vph.2016.07.003_bb0005","series-title":"Biomarker Validation \u2013 Technological, Clinical and Commercial Aspects","first-page":"107","article-title":"Bone remodeling biomarkers: new actors on the old cardiovascular stage","author":"Vassalle","year":"2015"},{"key":"10.1016\/j.vph.2016.07.003_bb0010","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.cca.2014.08.034","article-title":"SFBC\/SN joined working group on vascular calcifications. Vascular calcification: from pathophysiology to biomarkers","volume":"438","author":"Evrard","year":"2015","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.vph.2016.07.003_bb0015","doi-asserted-by":"publisher","first-page":"551","DOI":"10.5551\/jat.8656","article-title":"Osteo-progenitors in vascular calcification: a circulating cell theory","volume":"18","author":"Pal","year":"2011","journal-title":"J. Atheroscler. Thromb."},{"key":"10.1016\/j.vph.2016.07.003_bb0020","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1038\/ncomms1867","article-title":"Differentiation of multipotent vascular stem cells contributes to vascular diseases","volume":"3","author":"Tang","year":"2012","journal-title":"Nat. Commun."},{"key":"10.1016\/j.vph.2016.07.003_bb0025","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.yjmcc.2005.03.019","article-title":"Regulation of RANKL-induced osteoclastic differentiation by vascular cells","volume":"39","author":"Tintut","year":"2005","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.vph.2016.07.003_bb0030","doi-asserted-by":"publisher","first-page":"2938","DOI":"10.1161\/CIRCULATIONAHA.107.743161","article-title":"Vascular calcification: pathobiology of a multifaceted disease","volume":"117","author":"Demer","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2016.07.003_bb0035","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/j.ajpath.2010.10.006","article-title":"Elastin degradation and vascular smooth muscle cell phenotype change precede cell loss and arterial medial calcification in a uremic mouse model of chronic kidney disease","volume":"178","author":"Pai","year":"2011","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.vph.2016.07.003_bb0040","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1007\/s00774-005-0668-6","article-title":"Vascular calcification in chronic kidney disease","volume":"24","author":"Jono","year":"2006","journal-title":"J. Bone Miner. Metab."},{"key":"10.1016\/j.vph.2016.07.003_bb0045","article-title":"Mineral composition of phosphate-induced calcification in a rat aortic tissue culture model","volume":"27","author":"Sonou","year":"2015","journal-title":"J. Atheroscler. Thromb."},{"key":"10.1016\/j.vph.2016.07.003_bb0050","doi-asserted-by":"publisher","first-page":"8783","DOI":"10.1128\/MCB.20.23.8783-8792.2000","article-title":"Runx2 is a common target of transforming growth factor beta1 and bone morphogenetic protein 2, and cooperation between Runx2 and Smad5 induces osteoblast-specific gene expression in the pluripotent mesenchymal precursor cell line C2C12","volume":"20","author":"Lee","year":"2000","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.vph.2016.07.003_bb0055","doi-asserted-by":"publisher","first-page":"C210","DOI":"10.1152\/ajpcell.00229.2010","article-title":"Role of calcium-phosphate deposition in vascular smooth muscle cell calcification","volume":"300","author":"Villa-Bellosta","year":"2011","journal-title":"Am. J. Phys. Cell Physiol."},{"key":"10.1016\/j.vph.2016.07.003_bb0060","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.yexcr.2015.02.002","article-title":"Phosphate uptake-independent signaling functions of the type III sodium-dependent phosphate transporter, PiT-1, in vascular smooth muscle cells","volume":"333","author":"Chavkin","year":"2015","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.vph.2016.07.003_bb0065","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/ki.2010.390","article-title":"Hyperphosphatemia-induced nanocrystals upregulate the expression of bone morphogenetic protein-2 and osteopontin genes in mouse smooth muscle cells in vitro","volume":"79","author":"Sage","year":"2011","journal-title":"Kidney Int."},{"key":"10.1016\/j.vph.2016.07.003_bb0070","article-title":"Vascular calcification revisited: a new perspective for phosphate transport","volume":"5","author":"Villa-Bellosta","year":"2015","journal-title":"Curr. Cardiol. Rev."},{"key":"10.1016\/j.vph.2016.07.003_bb0075","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1038\/ki.2013.521","article-title":"Vascular calcification is dependent on plasma levels of pyrophosphate","volume":"85","author":"Lomashvili","year":"2014","journal-title":"Kidney Int."},{"key":"10.1016\/j.vph.2016.07.003_bb0080","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1001\/jama.2011.308","article-title":"Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis","volume":"305","author":"Palmer","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.vph.2016.07.003_bb0085","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.12622","article-title":"Recombinant PTH therapy for severe hypoparathyroidism after kidney transplantation in pre-transplant parathyroidectomized patients: review of the literature and a case report","author":"Hod","year":"2015","journal-title":"Clin. Transpl."},{"key":"10.1016\/j.vph.2016.07.003_bb0090","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1016\/j.bone.2008.07.250","article-title":"Differential effects of intermittent PTH(1-34) and PTH(7-34) on bone microarchitecture and aortic calcification in experimental renal failure","volume":"43","author":"Sebastian","year":"2008","journal-title":"Bone"},{"key":"10.1016\/j.vph.2016.07.003_bb0095","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1159\/000334424","article-title":"Increased levels of serum parathyroid hormone and fibroblast growth factor-23 are the main factors associated with the progression of vascular calcification in long-hour hemodialysis patients","volume":"120","author":"Jean","year":"2012","journal-title":"Nephron Clin. Pract."},{"key":"10.1016\/j.vph.2016.07.003_bb0100","doi-asserted-by":"publisher","first-page":"4041","DOI":"10.1093\/ndt\/gfq293","article-title":"Factors associated with aortic stiffness and its change over time in peritoneal dialysis patients","volume":"25","author":"Jung","year":"2010","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.vph.2016.07.003_bb0105","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1093\/ndt\/gfn686","article-title":"Phosphorus overload and PTH induce aortic expression of Runx2 in experimental uraemia","volume":"24","author":"Graciolli","year":"2009","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.vph.2016.07.003_bb0110","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s11154-015-9318-z","article-title":"The PTH-Vitamin D-FGF23 axis","volume":"16","author":"Blau","year":"2015","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"10.1016\/j.vph.2016.07.003_bb0115","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.mce.2015.06.005","article-title":"1, 25-Dihydroxyvitamin D3 and extracellular calcium promote mineral deposition via NPP1 activity in a mature osteoblast cell line MLO-A5","volume":"412","author":"Yang","year":"2015","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.vph.2016.07.003_bb0120","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1210\/en.2014-1744","article-title":"Calcitriol prevents in vitro vascular smooth muscle cell mineralization by regulating calcium-sensing receptor expression","volume":"156","author":"Mary","year":"2015","journal-title":"Endocrinology"},{"key":"10.1016\/j.vph.2016.07.003_bb0125","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1161\/CIRCRESAHA.110.216846","article-title":"Estrogen inhibits vascular calcification via vascular RANKL system: common mechanism of osteoporosis and vascular calcification","volume":"107","author":"Osako","year":"2010","journal-title":"Circ. Res."},{"key":"10.1016\/j.vph.2016.07.003_bb0130","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1210\/en.2013-1298","article-title":"Leptin promotes the osteoblastic differentiation of vascular smooth muscle cells from female mice by increasing RANKL expression","volume":"155","author":"Liu","year":"2014","journal-title":"Endocrinology"},{"key":"10.1016\/j.vph.2016.07.003_bb0135","first-page":"2545","article-title":"Globular adiponectin reduces vascular calcification via inhibition of ER-stress-mediated smooth muscle cell apoptosis","volume":"8","author":"Lu","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.vph.2016.07.003_bb0140","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.cjca.2013.11.005","article-title":"The mammalian target of rapamycin signalling pathway is involved in osteoblastic differentiation of vascular smooth muscle cells","volume":"30","author":"Zhan","year":"2014","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.vph.2016.07.003_bb0145","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.yexcr.2014.02.016","article-title":"Adiponectin attenuates the osteoblastic differentiation of vascular smooth muscle cells through the AMPK\/mTOR pathway","volume":"323","author":"Zhan","year":"2014","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.vph.2016.07.003_bb0150","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s00223-007-9004-6","article-title":"Association between systemic calcified atherosclerosis and bone density","volume":"80","author":"Hyder","year":"2007","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.vph.2016.07.003_bb0155","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1359\/jbmr.071024","article-title":"Abdominal aortic calcification detected on lateral spine images from a bone densitometer predicts incident myocardial infarction or stroke in older women","volume":"23","author":"Schousboe","year":"2008","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.vph.2016.07.003_bb0160","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1111\/j.1365-2796.2006.01640.x","article-title":"Radiographic measure of aorta calcification is a site-specific predictor of bone loss and fracture risk at the hip","volume":"259","author":"Bagger","year":"2006","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.vph.2016.07.003_bb0165","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1093\/aje\/kwn303","article-title":"Association of coronary artery and aortic calcium with lumbar bone density: the MESA Abdominal Aortic Calcium Study","volume":"169","author":"Hyder","year":"2009","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.vph.2016.07.003_bb0170","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1359\/jbmr.060903","article-title":"Volumetric BMD and vascular calcification in middle-aged women: the Study of Women's Health Across the Nation","volume":"21","author":"Farhat","year":"2006","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.vph.2016.07.003_bb0175","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/BF02390833","article-title":"Bone Loss and the progression of abdominal aortic calcification over a 25year period: the Framingham Heart Study","volume":"68","author":"Kiel","year":"2001","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.vph.2016.07.003_bb0180","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1161\/01.ATV.20.8.1926","article-title":"Progression of aortic calcification is associated with metacarpal bone loss during menopause: a population-based longitudinal study","volume":"20","author":"Hak","year":"2000","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.vph.2016.07.003_bb0185","doi-asserted-by":"publisher","first-page":"4246","DOI":"10.1210\/jc.2003-030964","article-title":"Aortic calcification and the risk of osteoporosis and fractures","volume":"89","author":"Schulz","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.vph.2016.07.003_bb0190","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/07435800.2013.794425","article-title":"Bone mineral density, vertebral fractures and body mass index in postmenopausal women with abdominal aortic calcification","volume":"39","author":"Simon","year":"2014","journal-title":"Endocr. Res."},{"key":"10.1016\/j.vph.2016.07.003_bb0195","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1359\/jbmr.070519","article-title":"Vascular calcification in middle age and long-term risk of hip fracture: the Framingham Study","volume":"22","author":"Samelson","year":"2007","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.vph.2016.07.003_bb0200","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1111\/j.1532-5415.1997.tb04498.x","article-title":"Bone mineral density and aortic calcification: the Study of Osteoporotic Fractures","volume":"45","author":"Vogt","year":"1997","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.vph.2016.07.003_bb0205","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1007\/s002230020003","article-title":"Low bone density is not associated with aortic calcification","volume":"69","author":"Aoyagi","year":"2001","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.vph.2016.07.003_bb0210","doi-asserted-by":"publisher","first-page":"R5","DOI":"10.1186\/ar3224","article-title":"(Sub)clinical cardiovascular disease is associated with increased bone loss and fracture risk; a systematic review of the association between cardiovascular disease and osteoporosis","volume":"13","author":"den Uyl","year":"2011","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.vph.2016.07.003_bb0215","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1093\/aje\/kwh252","article-title":"Low bone mineral density is related to echogenic carotid artery plaques: a population-based study","volume":"160","author":"Jorgensen","year":"2004","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.vph.2016.07.003_bb0220","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.maturitas.2014.05.017","article-title":"Carotid intima-media thickness and calcification in relation to bone mineral density in postmenopausal women-the OSTPRE-BBA study","volume":"78","author":"V\u00e4rri","year":"2014","journal-title":"Maturitas"},{"key":"10.1016\/j.vph.2016.07.003_bb0225","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1210\/er.2003-0015","article-title":"Molecular, endocrine, and genetic mechanisms of arterial calcification","volume":"25","author":"Doherty","year":"2004","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.vph.2016.07.003_bb0230","doi-asserted-by":"publisher","DOI":"10.1007\/s11914-015-0293-9","article-title":"Pathophysiology of vascular calcification","author":"Chen","year":"2015","journal-title":"Curr. Osteoporos. Rep."},{"key":"10.1016\/j.vph.2016.07.003_bb0235","doi-asserted-by":"publisher","first-page":"141","DOI":"10.3390\/jcdd2030141","article-title":"Vascular calcification and stone disease: a new look towards the mechanism","volume":"2","author":"Yiu","year":"2015","journal-title":"J. Cardiovasc. Dev. Dis."},{"key":"10.1016\/j.vph.2016.07.003_bb0240","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.atherosclerosis.2013.01.042","article-title":"Cathepsin K--a classical bone biomarker in cardiovascular disease: the heart is not alone anymore","volume":"228","author":"Vassalle","year":"2013","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.vph.2016.07.003_bb0245","doi-asserted-by":"publisher","first-page":"4629","DOI":"10.1093\/emboj\/20.17.4629","article-title":"Lysosomal cysteine proteases: facts and opportunities","volume":"20","author":"Turk","year":"2001","journal-title":"EMBO J."},{"key":"10.1016\/j.vph.2016.07.003_bb0250","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1126\/science.273.5279.1236","article-title":"Pycnodysostosis, a lysosomal disease caused by cathepsin K deficiency","volume":"273","author":"Gelb","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.vph.2016.07.003_bb0255","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/0-306-46826-3_32","article-title":"Functions of cathepsin K in bone resorption. Lessons from cathepsin K deficient mice","volume":"477","author":"Saftig","year":"2000","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.vph.2016.07.003_bb0260","doi-asserted-by":"publisher","first-page":"2841","DOI":"10.1161\/CIRCULATIONAHA.107.732867","article-title":"Osteogenesis associates with inflammation in early-stage atherosclerosis imaging in vivo","volume":"116","author":"Aikawa","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2016.07.003_bb0265","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1161\/CIRCULATIONAHA.105.561449","article-title":"Disruption of the cathepsin K gene reduces atherosclerosis progression and induces plaque fibrosis but accelerates macrophage foam cell formation","volume":"113","author":"Lutgens","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2016.07.003_bb0270","article-title":"Expression of the elastolytic cathepsins S and K in human atheroma and regulation of their production in smooth muscle cells","volume":"576\u201383","author":"Sukhova","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.vph.2016.07.003_bb0275","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1471-2261-10-19","article-title":"Human macrophage foam cells degrade atherosclerotic plaques through cathepsin K mediated processes","volume":"10","author":"Barascuk","year":"2010","journal-title":"BMC Cardiovasc. Disord."},{"key":"10.1016\/j.vph.2016.07.003_bb0280","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1161\/01.ATV.0000228824.01604.63","article-title":"Increased expression of elastolytic cathepsins S, K, and V and their inhibitor cystatin C in stenotic aortic valves","volume":"26","author":"Helske","year":"2006","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.vph.2016.07.003_bb0285","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.atherosclerosis.2013.01.004","article-title":"Circulating CatK as a potential novel biomarker of coronary artery disease","volume":"228","author":"Cheng","year":"2013","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.vph.2016.07.003_bb0290","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1507\/endocrj.K08E-143","article-title":"Cathepsin K regulates adipocyte differentiation: possible involvement of type I collagen degradation","volume":"56","author":"Han","year":"2009","journal-title":"Endocr. J."},{"key":"10.1016\/j.vph.2016.07.003_bb0295","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2016.02.053","article-title":"Treatments for post-menopausal osteoporotic women, what's new? How can we manage long-term treatment?","author":"Herrero","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.vph.2016.07.003_bb0300","article-title":"Cathepsin K inhibition: a new mechanism for the treatment of osteoporosis","volume":"3","author":"Duong","year":"2015","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.vph.2016.07.003_bb0305","doi-asserted-by":"publisher","DOI":"10.2217\/whe.15.39","article-title":"Odanacatib: an emerging novel treatment alternative for postmenopausal osteoporosis","author":"Schultz","year":"2015","journal-title":"Women's Health (Lond. Engl.)"},{"issue":"2","key":"10.1016\/j.vph.2016.07.003_bb0310","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/S0092-8674(00)80209-3","article-title":"Osteoprotegerin: a novel secreted protein involved in the regulation of bone density","volume":"89","author":"Simonet","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.vph.2016.07.003_bb0315","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1159\/000358920","article-title":"Increased calcification in osteoprotegerin-deficient smooth muscle cells: dependence on receptor activator of NF-kB ligand and interleukin 6","volume":"51","author":"Callegari","year":"2014","journal-title":"J. Vasc. Res."},{"key":"10.1016\/j.vph.2016.07.003_bb0320","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.4049\/jimmunol.166.3.1482","article-title":"Osteoprotegerin a crucial regulator of bone metabolism, also regulates B cell development and function","volume":"166","author":"Yun","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.vph.2016.07.003_bb0325","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.jsbmb.2013.09.008","article-title":"Prevention and treatment of postmenopausal osteoporosis","volume":"142","author":"Tella","year":"2014","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.vph.2016.07.003_bb0330","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1101\/gad.12.9.1260","article-title":"Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification","volume":"12","author":"Bucay","year":"1998","journal-title":"Genes Dev."},{"key":"10.1016\/j.vph.2016.07.003_bb0335","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1161\/01.ATV.0000204334.48195.6a","article-title":"Enhanced T-cell expression of RANK ligand in acute coronary syndrome: possible role in plaque destabilization","volume":"26","author":"Sandberg","year":"2006","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.vph.2016.07.003_bb0340","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1161\/01.ATV.0000236428.91125.e6","article-title":"Osteoprotegerin inactivation accelerates advanced atherosclerotic lesion progression and calcification in older ApoE-\/- mice","volume":"26","author":"Bennett","year":"2006","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.vph.2016.07.003_bb0345","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1161\/01.STR.0000129790.00318.a3","article-title":"Osteoprotegerin and osteopontin are expressed at high concentrations within symptomatic carotid atherosclerosis","volume":"35","author":"Golledge","year":"2004","journal-title":"Stroke"},{"key":"10.1016\/j.vph.2016.07.003_bb0350","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0107642","article-title":"Osteoprotegerin, pericytes and bone-like vascular calcification are associated with carotid plaque stability","volume":"9","author":"Davaine","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.vph.2016.07.003_bb0355","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.advms.2014.08.002","article-title":"Circulating osteoprotegerin and asymptomatic carotid atherosclerosis in postmenopausal non diabetic women","volume":"59","author":"Albu","year":"2014","journal-title":"Adv. Med. Sci."},{"key":"10.1016\/j.vph.2016.07.003_bb0360","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1016\/j.ijcard.2012.05.001","article-title":"Serum osteoprotegerin and osteopontin levels are associated with arterial stiffness and the presence and severity of coronary artery disease","volume":"167","author":"Tousoulis","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.vph.2016.07.003_bb0365","doi-asserted-by":"publisher","first-page":"564934","DOI":"10.1155\/2015\/564934","article-title":"Osteoprotegerin in cardiometabolic disorders","volume":"2015","author":"P\u00e9rez de Ciriza","year":"2015","journal-title":"Int. J. Endocrinol."},{"key":"10.1016\/j.vph.2016.07.003_bb0370","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.clinbiochem.2014.09.004","article-title":"Circulating osteoprotegerin is increased in the metabolic syndrome and associates with subclinical atherosclerosis and coronary arterial calcification","volume":"47","author":"P\u00e9rez de Ciriza","year":"2014","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.vph.2016.07.003_bb0375","doi-asserted-by":"publisher","first-page":"203","DOI":"10.3109\/14017431.2012.685491","article-title":"Osteoprotegerin as a marker of atherosclerosis: a systematic update","volume":"46","author":"Hosbond","year":"2012","journal-title":"Scand. Cardiovasc. J."},{"key":"10.1016\/j.vph.2016.07.003_bb0380","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1590\/1414-431X20144007","article-title":"Elevated levels of plasma osteoprotegerin are associated with all-cause mortality risk and atherosclerosis in patients with stages 3 to 5 chronic kidney disease","volume":"47","author":"Nascimento","year":"2014","journal-title":"Braz. J. Med. Biol. Res."},{"key":"10.1016\/j.vph.2016.07.003_bb0385","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1016\/j.cjca.2015.04.003","article-title":"Prognostic value of osteoprotegerin in acute heart failure","volume":"31","author":"Fri\u00f5es","year":"2015","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.vph.2016.07.003_bb0390","doi-asserted-by":"publisher","first-page":"657","DOI":"10.3109\/00365513.2014.930510","article-title":"Osteoprotegerin independently predicts mortality in patients with stable coronary artery disease: the CLARICOR trial","volume":"74","author":"Bjerre","year":"2014","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"10.1016\/j.vph.2016.07.003_bb0395","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0134266","article-title":"Elevated circulating osteoprotegerin and renal dysfunction predict 15-year cardiovascular and all-cause mortality: a prospective study of elderly women","volume":"10","author":"Lewis","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.vph.2016.07.003_bb0400","doi-asserted-by":"publisher","first-page":"738","DOI":"10.3109\/1354750X.2012.727027","article-title":"Association of plasma osteoprotegerin levels with stroke severity and functional outcome in acute ischaemic stroke patients","volume":"17","author":"Song","year":"2012","journal-title":"Biomarkers"},{"key":"10.1016\/j.vph.2016.07.003_bb0405","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1093\/cvr\/cvr084","article-title":"Calcium and osteoprotegerin regulate IGF1R expression to inhibit vascular calcification","volume":"91","author":"Di Bartolo","year":"2011","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.vph.2016.07.003_bb0410","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1182\/blood-2007-01-068395","article-title":"Osteoprotegerin increases leukocyte adhesion to endothelial cells both in vitro and in vivo","volume":"110","author":"Zauli","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.vph.2016.07.003_bb0415","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.cardiores.2007.07.017","article-title":"Osteoprotegerin upregulates endothelial cell adhesion molecule response to tumour necrosis factor-a associated with induction of angiopoietin-2","volume":"76","author":"Mangan","year":"2007","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.vph.2016.07.003_bb0420","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1177\/1074248413511692","article-title":"Effects of combination therapy with olmesartan and azelnidipine on serum osteoprotegerin in patients with hypertension","volume":"19","author":"Uzui","year":"2014","journal-title":"J. Cardiovasc. Pharmacol. Ther."},{"key":"10.1016\/j.vph.2016.07.003_bb0425","doi-asserted-by":"publisher","first-page":"3122","DOI":"10.2337\/dc07-0919","article-title":"Simvastatin reduces plasma osteoprotegerin in type 2 diabetic patients with microalbuminuria","volume":"30","author":"Nellemann","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.vph.2016.07.003_bb0430","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1177\/0003319708330525","article-title":"Effects of pravastatin on serum osteoprotegerin levels in patients with hypercholesterolemia and type 2 diabetes","volume":"61","author":"Mori","year":"2010","journal-title":"Angiology"},{"key":"10.1016\/j.vph.2016.07.003_bb0435","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1016\/j.clinbiochem.2010.08.012","article-title":"Lovastatin raises serum osteoprotegerin level in people with type 2 diabetic nephropathy","volume":"43","author":"Nezami","year":"2010","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.vph.2016.07.003_bb0440","first-page":"18","article-title":"The influence of statins on levels of calcification biomarkers in patients with aortic sclerosis or mild aortic stenosis","volume":"20","author":"Dimitrow","year":"2011","journal-title":"J. Heart Valve Dis."},{"key":"10.1016\/j.vph.2016.07.003_bb0445","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1530\/EJE-14-1137","article-title":"The effects of insulin and liraglutide on osteoprotegerin and vascular calcification in vitro and in patients with type 2 diabetes","volume":"173","author":"Davenport","year":"2015","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.vph.2016.07.003_bb0450","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1177\/10454411000110030101","article-title":"Osteopontin","volume":"11","author":"Sodek","year":"2000","journal-title":"Crit. Rev. Oral Biol. Med."},{"key":"10.1016\/j.vph.2016.07.003_bb0455","doi-asserted-by":"publisher","first-page":"15","DOI":"10.2310\/JIM.0b013e3182761264","article-title":"The value of osteopontin in the assessment of bone mineral density status in postmenopausal women","volume":"61","author":"Fodor","year":"2013","journal-title":"J. Investig. Med."},{"key":"10.1016\/j.vph.2016.07.003_bb0460","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3109\/00365513.2015.1087045","article-title":"Serum osteopontin levels in relation to bone mineral density and bone turnover markers in postmenopausal women","volume":"76","author":"Wei","year":"2016","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"10.1016\/j.vph.2016.07.003_bb0465","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1007\/s00198-009-1107-7","article-title":"Increased serum osteopontin is a risk factor for osteoporosis in menopausal women","volume":"21","author":"Chang","year":"2010","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.vph.2016.07.003_bb0470","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.molmet.2014.03.004","article-title":"Osteopontin: a novel regulator at the cross roads of inflammation, obesity and diabetes","volume":"3","author":"Kahles","year":"2014","journal-title":"Mol Metab."},{"key":"10.1016\/j.vph.2016.07.003_bb0475","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1172\/JCI116755","article-title":"Osteopontin is elevated during neointima formation in rat arteries and is a novel component of human atherosclerotic plaques","volume":"92","author":"Giachelli","year":"1993","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.vph.2016.07.003_bb0480","doi-asserted-by":"publisher","first-page":"2814","DOI":"10.1172\/JCI116901","article-title":"Osteopontin mRNA is expressed by smooth muscle-derived foam cells in human atherosclerotic lesions of the aorta","volume":"92","author":"Ikeda","year":"1993","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.vph.2016.07.003_bb0485","doi-asserted-by":"publisher","first-page":"570698","DOI":"10.1155\/2014\/570698","article-title":"Serum osteopontin level correlates with carotid-femoral pulse wave velocity in geriatric persons","volume":"2014","author":"Lee","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.vph.2016.07.003_bb0490","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1161\/01.ATV.0000194157.26665.e6","article-title":"High plasma levels of osteopontin in patients with restenosis after percutaneous coronary intervention","volume":"26","author":"Kato","year":"2006","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.vph.2016.07.003_bb0495","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.atherosclerosis.2011.04.032","article-title":"A pattern of disperse plaque microcalcifications identifies a subset of plaques with high inflammatory burden in patients with acute myocardial infarction","volume":"218","author":"Li","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.vph.2016.07.003_bb0500","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1111\/eci.12446","article-title":"Serum osteopontin levels are upregulated and predict disability after an ischaemic stroke","volume":"45","author":"Carbone","year":"2015","journal-title":"Eur. J. Clin. Investig."},{"key":"10.1016\/j.vph.2016.07.003_bb0505","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1177\/2047487313487083","article-title":"High osteopontin levels predict long-term outcome after STEMI and primary percutaneous coronary intervention","volume":"20","author":"Bjerre","year":"2013","journal-title":"Eur. J. Prev. Cardiol."},{"key":"10.1016\/j.vph.2016.07.003_bb0510","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1161\/01.RES.84.2.166","article-title":"Calcification of vascular smooth muscle cell cultures: inhibition by osteopontin","volume":"84","author":"Wada","year":"1999","journal-title":"Circ. Res."},{"key":"10.1016\/j.vph.2016.07.003_bb0515","doi-asserted-by":"publisher","first-page":"20197","DOI":"10.1074\/jbc.M909174199","article-title":"Phosphorylation of osteopontin is required for inhibition of vascular smooth muscle cell calcification","volume":"275","author":"Jono","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.vph.2016.07.003_bb0520","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1002\/jcb.21558","article-title":"Control of osteopontin signaling and function by post-translational phosphorylation and protein folding","volume":"102","author":"Kazanecki","year":"2007","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.vph.2016.07.003_bb0525","doi-asserted-by":"publisher","first-page":"111","DOI":"10.3109\/1354750X.2011.642407","article-title":"Dephosphorylation of circulating human osteopontin correlates with severe valvular calcification in patients with calcific aortic valve disease","volume":"17","author":"Sainger","year":"2012","journal-title":"Biomarkers"},{"key":"10.1016\/j.vph.2016.07.003_bb0530","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.atherosclerosis.2009.09.009","article-title":"Angiotensin II receptor blocker and statins lower elevated levels of osteopontin in essential hypertension\u2014results from the EUTOPIA trial","volume":"209","author":"Lorenzen","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.vph.2016.07.003_bb0535","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.atherosclerosis.2014.04.037","article-title":"New insights for matrix Gla protein, vascular calcification and cardiovascular risk and outcome","volume":"235","author":"Vassalle","year":"2014","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.vph.2016.07.003_bb0540","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/386078a0","article-title":"Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein","volume":"386","author":"Luo","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.vph.2016.07.003_bb0545","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1161\/CIRCRESAHA.110.219071","article-title":"Inhibition of bone morphogenetic proteins protects against atherosclerosis and vascular calcification","volume":"107","author":"Yao","year":"2010","journal-title":"Circ. Res."},{"key":"10.1016\/j.vph.2016.07.003_bb0550","doi-asserted-by":"publisher","first-page":"18406","DOI":"10.1021\/ja207628k","article-title":"Matrix Gla protein inhibits ectopic calcification by a direct interaction with hydroxyapatite crystals","volume":"133","author":"O'Young","year":"2011","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.vph.2016.07.003_bb0555","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1046\/j.1538-7836.2003.00023.x","article-title":"Matrix Gla protein (MGP) and bone morphogenetic protein-2 in aortic calcified lesions of aging rats","volume":"1","author":"Sweatt","year":"2003","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.vph.2016.07.003_bb0560","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/1471-2369-15-145","article-title":"Dephosphorylated-uncarboxylated Matrix Gla protein concentration is predictive of vitamin K status and is correlated with vascular calcification in a cohort of hemodialysis patients","volume":"15","author":"Delanaye","year":"2014","journal-title":"BMC Nephrol."},{"key":"10.1016\/j.vph.2016.07.003_bb0565","doi-asserted-by":"publisher","first-page":"3766","DOI":"10.2337\/dc13-0065","article-title":"Matrix Gla protein species and risk of cardiovascular events in type 2 diabetic patients","volume":"36","author":"Dalmeijer","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.vph.2016.07.003_bb0570","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1161\/HYPERTENSIONAHA.115.05177","article-title":"Inactive matrix Gla-protein is associated with arterial stiffness in an adult population-based study","volume":"66","author":"Pivin","year":"2015","journal-title":"Hypertension"},{"key":"10.1016\/j.vph.2016.07.003_bb0575","article-title":"Desphospho-uncarboxylated matrix Gla protein is associated with increased aortic stiffness in a general population","author":"Mayer","year":"2015","journal-title":"J. Hum. Hypertens."},{"key":"10.1016\/j.vph.2016.07.003_bb0580","unstructured":"Mayer O, Seidlerov\u00e1 J, Bruthans J, Filipovsk\u00fd J,Timorack\u00e1 K, Van\u011bk J, \u010cern\u00e1 L, Wohlfahrt P, C\u00edfkov\u00e1 R, Theuwissen E, Vermeer C. Desphosho-uncarboxylated matrix gla-protein is associated with mortality risk in patients with chronic stable vascular disease. Atherosclerosis in press in."},{"key":"10.1016\/j.vph.2016.07.003_bb0585","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.maturitas.2013.10.008","article-title":"Circulating uncarboxylated matrix Gla protein, a marker of vitamin K status, as a risk factor of cardiovascular disease","volume":"77","author":"van den Heuvel","year":"2014","journal-title":"Maturitas"},{"key":"10.1016\/j.vph.2016.07.003_bb0590","doi-asserted-by":"publisher","first-page":"568","DOI":"10.2215\/CJN.07081009","article-title":"The circulating inactive form of matrix gla protein is a surrogate marker for vascular calcification in chronic kidney disease: a preliminary report","volume":"5","author":"Schurgers","year":"2010","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.vph.2016.07.003_bb0595","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.bone.2012.10.007","article-title":"Vitamin D signaling in osteocytes: effects on bone and mineral homeostasis","volume":"54","author":"Lieben","year":"2013","journal-title":"Bone"},{"key":"10.1016\/j.vph.2016.07.003_bb0600","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.semnephrol.2014.09.005","article-title":"New insights into the FGF23-Klotho axis","volume":"34","author":"Olauson","year":"2014","journal-title":"Semin. Nephrol."},{"key":"10.1016\/j.vph.2016.07.003_bb0605","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.abb.2011.11.003","article-title":"25-Hydroxyvitamin D-24-hydroxylase (CYP24A1): its important role in the degradation of vitamin D","volume":"523","author":"Jones","year":"2012","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.vph.2016.07.003_bb0610","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1016\/j.yexcr.2012.02.027","article-title":"Role of FGF23 in vitamin D and phosphate metabolism: implications in chronic kidney disease","volume":"318","author":"Quarles","year":"2012","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.vph.2016.07.003_bb0615","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.abb.2010.06.028","article-title":"The bone and the kidney","volume":"503","author":"Mazzaferro","year":"2010","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.vph.2016.07.003_bb0620","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/ijos.2015.1","article-title":"Fibroblast growth factor 23 and bone mineralisation","volume":"7","author":"Guo","year":"2015","journal-title":"Int. J. Oral Sci."},{"key":"10.1016\/j.vph.2016.07.003_bb0625","doi-asserted-by":"publisher","first-page":"3702","DOI":"10.1096\/fj.08-123992","article-title":"Inactivation of Klotho function induces hyperphosphatemia even in presence of high serum fibroblast growth factor 23 levels in a genetically engineered hypophosphatemic (Hyp) mouse model","volume":"23","author":"Nakatani","year":"2009","journal-title":"FASEB J."},{"key":"10.1016\/j.vph.2016.07.003_bb0630","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/nrneph.2014.49","article-title":"Roles of phosphate and fibroblast growth factor 23 in cardiovascular disease","volume":"10","author":"Scialla","year":"2014","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.vph.2016.07.003_bb0635","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1681\/ASN.2013050465","article-title":"Fibroblast growth factor-23 and cardiovascular events in CKD","volume":"25","author":"Scialla","year":"2014","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.vph.2016.07.003_bb0640","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1681\/ASN.2013050465","article-title":"Fibroblast growth factor-23 and cardiovascular events in CKD","volume":"25","author":"Hamano","year":"2014","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.vph.2016.07.003_bb0645","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1056\/NEJMoa0706130","article-title":"Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis","volume":"359","author":"Gutierrez","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.vph.2016.07.003_bb0650","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1111\/joim.12232","article-title":"The fibroblast growth factor-23 and Vitamin D emerge as nontraditional risk factors and may affect cardiovascular risk","volume":"277","author":"Masson","year":"2015","journal-title":"J. Intern. Med."},{"issue":"7","key":"10.1016\/j.vph.2016.07.003_bb0655","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1161\/CIRCHEARTFAILURE.113.000952","article-title":"Fibroblast growth factor-23 and cardiovascular disease in the general population: the Multi-Ethnic Study of Atherosclerosis","author":"Kestenbaum","year":"2014","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.vph.2016.07.003_bb0660","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1161\/ATVBAHA.110.214619","article-title":"Circulating fibroblast growth factor-23 is associated with fat mass and dyslipidemia in two independent cohorts of elderly individuals","volume":"31","author":"Mirza","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.vph.2016.07.003_bb0665","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.2215\/CJN.09250912","article-title":"Effects of dietary phosphate restriction and phosphate binders on FGF23 levels in CKD","volume":"8","author":"Isakova","year":"2013","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.vph.2016.07.003_bb0670","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1053\/j.ajkd.2011.11.007","article-title":"Comparison of calcium acetate and sevelamer on vascular function and fibroblast growth factor 23 in CKD patients: a randomized clinical trial","volume":"59","author":"Yilmaz","year":"2012","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.vph.2016.07.003_bb0675","doi-asserted-by":"publisher","first-page":"257","DOI":"10.2215\/CJN.05040610","article-title":"Vegetarian compared with meat dietary protein source and phosphorus homeostasis in chronic kidney disease","volume":"6","author":"Moe","year":"2011","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.vph.2016.07.003_bb0680","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0047338","article-title":"Accelerated growth plate mineralization and foreshortened proximal limb bones in fetuin-A knockout mice","volume":"7","author":"Seto","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.vph.2016.07.003_bb0685","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1161\/CIRCRESAHA.111.261479","article-title":"Clearance of fetuin-A-containing calciprotein particles is mediated by scavenger receptor-A","volume":"111","author":"Herrmann","year":"2012","journal-title":"Circ. Res."},{"key":"10.1016\/j.vph.2016.07.003_bb0690","article-title":"Fetuin-A-containing calciprotein particles reduce mineral stress in the macrophage","volume":"8","author":"Smith","year":"2013","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.vph.2016.07.003_bb0695","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1007\/s00198-010-1439-3","article-title":"The relationship of fetuin-A and lactoferrin with bone mass in elderly women","volume":"22","author":"Chailurkit","year":"2011","journal-title":"Osteoporos. Int."},{"issue":"4","key":"10.1016\/j.vph.2016.07.003_bb0700","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1111\/j.1365-2265.2011.04246.x","article-title":"Levels of fetuin-A relate to the levels of bone turnover biomarkers in male and female patients with type 2 diabetes","volume":"76","author":"Rasul","year":"2012","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.vph.2016.07.003_bb0705","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/1471-2369-14-122","article-title":"Associations of fetuin-A and osteoprotegerin with arterial stiffness and early atherosclerosis in chronic hemodialysis patients","volume":"14","author":"Pateinakis","year":"2013","journal-title":"BMC Nephrol."},{"key":"10.1016\/j.vph.2016.07.003_bb0710","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1177\/0003319713497421","article-title":"Association between serum fetuin-A levels, carotid artery stiffness, and intima-media thickness in patients with normotensive obstructive sleep apnea syndrome","volume":"65","author":"Akyuz","year":"2014","journal-title":"Angiology"},{"key":"10.1016\/j.vph.2016.07.003_bb0715","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1038\/nrneph.2014.8","article-title":"Noncardiovascular mortality in CKD: an epidemiological perspective","volume":"10","author":"de Jager","year":"2014","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.vph.2016.07.003_bb0720","first-page":"375","article-title":"The role of fetuin-A in cardiac functions and metabolism in peritoneal dialysis patients","volume":"67","author":"Aydin","year":"2015","journal-title":"Minerva Urol. Nefrol."},{"key":"10.1016\/j.vph.2016.07.003_bb0725","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1155\/2013\/846059","article-title":"Biomarkers associated with vascular and valvular calcification in chronic hemodialysis patients","volume":"34","author":"Lee","year":"2013","journal-title":"Dis. Markers"},{"key":"10.1016\/j.vph.2016.07.003_bb0730","first-page":"11","article-title":"Negative correlation between fetuin-A and indices of vascular disease in systemic lupus erythematosus patients with and without lupus nephritis","volume":"6","author":"Abdel-Wahab","year":"2013","journal-title":"Arab. J. Nephrol. Transplant."},{"key":"10.1016\/j.vph.2016.07.003_bb0735","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.bone.2015.06.004","article-title":"Serum fetuin-A levels and abdominal aortic calcification in healthy men - the STRAMBO study","volume":"79","author":"Schoppet","year":"2015","journal-title":"Bone"},{"key":"10.1016\/j.vph.2016.07.003_bb0740","doi-asserted-by":"publisher","first-page":"745","DOI":"10.2215\/CJN.05450513","article-title":"Biomarkers of vascular calcification and mortality in patients with ESRD","volume":"9","author":"Scialla","year":"2014","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.vph.2016.07.003_bb0745","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.114.000939","article-title":"Plasma levels of fetuin-A and risk of coronary heart disease in US women: the Nurses' Health Study","volume":"3","author":"Sun","year":"2014","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.vph.2016.07.003_bb0750","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1111\/jre.12015","article-title":"Impact of matrix metalloproteinases on inhibition of mineralization by fetuin","volume":"48","author":"Schure","year":"2013","journal-title":"J. Periodontal Res."},{"key":"10.1016\/j.vph.2016.07.003_bb0755","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1111\/j.2042-7158.2012.01561.x","article-title":"Role of fetuin-A in atherosclerosis associated with diabetic patients","volume":"64","author":"Singh","year":"2012","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.vph.2016.07.003_bb0760","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1042\/CS20120542","article-title":"Fetuin-A mRNA expression is elevated in NASH compared with NAFL patients","volume":"125","author":"Kahraman","year":"2013","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.vph.2016.07.003_bb0765","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1038\/nm.2851","article-title":"Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance","volume":"18","author":"Pal","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.vph.2016.07.003_bb0770","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1097\/JIM.0000000000000153","article-title":"Associations of fibroblast growth factor 23 and fetuin-A with coronary plaque burden and plaque composition in young adults","volume":"63","author":"Akin","year":"2015","journal-title":"J. Investig. Med."},{"key":"10.1016\/j.vph.2016.07.003_bb0775","first-page":"991","article-title":"Association of plasma Fetuin-A and clinical characteristics in patients with new-onset type 2 diabetes mellitus","volume":"8","author":"Yin","year":"2015","journal-title":"Int. J. Clin. Exp. Med."},{"key":"10.1016\/j.vph.2016.07.003_bb0780","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s40261-013-0157-y","article-title":"Serum levels of fetuin-A, osteoprotegerin and osteopontin in patients with coronary artery disease: effects of statin (HMGCoA-reductase inhibitor) therapy","volume":"34","author":"Kadoglou","year":"2014","journal-title":"Clin. Drug Investig."},{"key":"10.1016\/j.vph.2016.07.003_bb0785","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/1471-2369-15-130","article-title":"The influence of vitamin D analogs on calcification modulators, N-terminal pro-B-type natriuretic peptide and inflammatory markers in hemodialysis patients: a randomized crossover study","volume":"15","author":"Hansen","year":"2014","journal-title":"BMC Nephrol."},{"key":"10.1016\/j.vph.2016.07.003_bb0790","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.nutres.2012.06.005","article-title":"Omega-3 fatty acid supplementation increases 1,25-dihydroxyvitamin D and fetuin-A levels in dialysis patients","volume":"32","author":"An","year":"2012","journal-title":"Nutr. Res."},{"key":"10.1016\/j.vph.2016.07.003_bb0795","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00017.2015","article-title":"Fetuin-A decrease induced by a low protein diet enhances vascular calcification in uremic rats with hyperphosphatemia","author":"Yamada","year":"2015","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.vph.2016.07.003_bb0800","doi-asserted-by":"publisher","first-page":"4877","DOI":"10.1210\/jc.2010-0148","article-title":"Elevated Fetuin-A concentrations in morbid obesity decrease after dramatic weight loss","volume":"95","author":"Brix","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.vph.2016.07.003_bb0805","doi-asserted-by":"publisher","first-page":"3187","DOI":"10.1007\/s00018-012-1231-y","article-title":"Regulatory circuits controlling vascular cell calcification","volume":"70","author":"Sallam","year":"2013","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.vph.2016.07.003_bb0810","doi-asserted-by":"publisher","first-page":"619","DOI":"10.5301\/jn.5000187","article-title":"Bone-vascular cross-talk","volume":"25","author":"London","year":"2012","journal-title":"J. Nephrol."},{"key":"10.1016\/j.vph.2016.07.003_bb0815","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1111\/j.1365-2362.2011.02545.x","article-title":"Effects of inflammatory and anti-inflammatory cytokines on the bone","volume":"41","author":"Schett","year":"2011","journal-title":"Eur. J. Clin. Investig."},{"key":"10.1016\/j.vph.2016.07.003_bb0820","first-page":"712","article-title":"Elevated levels of oxidative stress as a prognostic predictor of major adverse cardiovascular events in patients with coronary artery disease","volume":"19","author":"Vassalle","year":"2012","journal-title":"J. Atheroscler. Thromb."},{"key":"10.1016\/j.vph.2016.07.003_bb0825","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1016\/j.clinbiochem.2008.07.005","article-title":"An oxidative stress score as a combined measure of the pro-oxidant and anti-oxidant counterparts in patients with coronary artery disease","volume":"41","author":"Vassalle","year":"2008","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.vph.2016.07.003_bb0830","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1093\/jmcb\/mjr021","article-title":"Osteoclast precursor differentiation by MCPIP via oxidative stress, endoplasmic reticulum stress, and autophagy","volume":"3","author":"Wang","year":"2011","journal-title":"J. Mol. Cell Biol."},{"key":"10.1016\/j.vph.2016.07.003_bb0835","doi-asserted-by":"publisher","first-page":"206","DOI":"10.3109\/10715762.2013.859387","article-title":"Methylglyoxal induces oxidative stress and mitochondrial dysfunction in osteoblastic MC3T3-E1 cells","volume":"48","author":"Suh","year":"2014","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.vph.2016.07.003_bb0840","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1161\/CIRCULATIONAHA.106.654913","article-title":"Multimodality molecular imaging identifies proteolytic and osteogenic activities in early aortic valve disease","volume":"115","author":"Aikawa","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2016.07.003_bb0845","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1159\/000341216","article-title":"RANKL enhances macrophage paracrine pro-calcific activity in high phosphate-treated smooth muscle cells: dependence on IL-6 and TNF-\u03b1","volume":"49","author":"Deuell","year":"2012","journal-title":"J. Vasc. Res."},{"key":"10.1016\/j.vph.2016.07.003_bb0850","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1016\/j.jacc.2003.12.041","article-title":"Neoangiogenesis, T-lymphocyte infiltration, and heat shock protein-60 are biological hallmarks of an immunomediated inflammatory process in end-stage calcified aortic valve stenosis","volume":"43","author":"Mazzone","year":"2004","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.vph.2016.07.003_bb0855","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1309\/W75NTE5QBC9DXE03","article-title":"Biological features (inflammation and neoangiogenesis) and atherosclerotic risk factors in carotid plaques and calcified aortic valve stenosis: two different sites of the same disease?","volume":"126","author":"Mazzone","year":"2006","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.vph.2016.07.003_bb0860","article-title":"Inflammation and the bone-vascular axis in end-stage renal disease","author":"Viaene","year":"2015","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.vph.2016.07.003_bb0865","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1517\/14728222.2014.894021","article-title":"Ectopic calcification in diabetic vascular disease","volume":"18","author":"Avogaro","year":"2014","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.vph.2016.07.003_bb0870","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1681\/ASN.2004100835","article-title":"Low turnover osteodystrophy and vascular calcification are amenable to skeletal anabolism in an animal model of chronic kidney disease and the metabolic syndrome","volume":"16","author":"Davies","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.vph.2016.07.003_bb0875","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.bone.2013.08.021","article-title":"Prevention of arterial calcification corrects the low bone mass phenotype in MGP-deficient mice","volume":"57","author":"Marulanda","year":"2013","journal-title":"Bone"},{"key":"10.1016\/j.vph.2016.07.003_bb0880","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.bone.2009.09.006","article-title":"High phosphorus diet induces vascular calcification, a related decrease in bone mass and changes in the aortic gene expression","volume":"46","author":"Rom\u00e1n-Garc\u00eda","year":"2010","journal-title":"Bone"},{"key":"10.1016\/j.vph.2016.07.003_bb0885","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1148\/radiol.2263020338","article-title":"The iceman: discovery and imaging","volume":"226","author":"Murphy","year":"2003","journal-title":"Radiology"},{"key":"10.1016\/j.vph.2016.07.003_bb0890","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.metabol.2007.11.024","article-title":"Physical activity, coronary artery calcium, and bone mineral density in elderly men and women: a preliminary investigation","volume":"57","author":"Wilund","year":"2008","journal-title":"Metabolism"},{"key":"10.1016\/j.vph.2016.07.003_bb0895","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1007\/s00774-011-0278-4","article-title":"Soy protein diet and exercise training increase relative bone volume and enhance bone microarchitecture in a mouse model of uremia","volume":"29","author":"Tomayko","year":"2011","journal-title":"J. Bone Miner. Metab."},{"key":"10.1016\/j.vph.2016.07.003_bb0900","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1089\/jmf.2012.0219","article-title":"Resveratrol supplementation reduces aortic atherosclerosis and calcification and attenuates loss of aerobic capacity in a mouse model of uremia","volume":"17","author":"Tomayko","year":"2014","journal-title":"J. Med. Food"},{"key":"10.1016\/j.vph.2016.07.003_bb0905","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.2174\/13894501113149990195","article-title":"Update on statins: hope for osteoporotic fracture healing treatment","volume":"14","author":"Ibrahim","year":"2013","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.vph.2016.07.003_bb0910","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s00223-015-9975-7","article-title":"The effects of atorvastatin on the prevention of osteoporosis and dyslipidemia in the high-fat-fed ovariectomized rats","volume":"96","author":"Lin","year":"2015","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.vph.2016.07.003_bb0915","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.12659\/MSM.892247","article-title":"Single-dose local simvastatin injection improves implant fixation via increased angiogenesis and bone formation in an ovariectomized rat model","volume":"21","author":"Tan","year":"2015","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.vph.2016.07.003_bb0920","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.archger.2014.07.006","article-title":"Effects of atorvastatin on bone mineral density (BMD) and bone metabolism in elderly males with osteopenia and mild dyslipidemia: a 1-year randomized trial","volume":"59","author":"Chen","year":"2014","journal-title":"Arch. Gerontol. Geriatr."},{"key":"10.1016\/j.vph.2016.07.003_bb0925","doi-asserted-by":"publisher","first-page":"468397","DOI":"10.1155\/2014\/468397","article-title":"Effect of simvastatin and atorvastatin on serum vitamin d and bone mineral density in hypercholesterolemic patients: a cross-sectional study","volume":"2014","author":"Thabit","year":"2014","journal-title":"J. Osteoporos."},{"key":"10.1016\/j.vph.2016.07.003_bb0930","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1159\/000381703","article-title":"Atorvastatin attenuates bone loss and aortic valve atheroma in LDLR mice","volume":"132","author":"Rajamannan","year":"2015","journal-title":"Cardiology"},{"key":"10.1016\/j.vph.2016.07.003_bb0935","article-title":"Dual effects of bisphosphonates on ectopic skin and vascular soft tissue mineralization versus bone microarchitecture in a mouse model of generalized arterial calcification of infancy","author":"Li","year":"2015","journal-title":"J. Invest. Dermatol."}],"container-title":["Vascular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189115300859?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189115300859?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,10]],"date-time":"2018-09-10T14:58:49Z","timestamp":1536591529000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1537189115300859"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":187,"alternative-id":["S1537189115300859"],"URL":"https:\/\/doi.org\/10.1016\/j.vph.2016.07.003","relation":{},"ISSN":["1537-1891"],"issn-type":[{"value":"1537-1891","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bone loss and vascular calcification: A bi-directional interplay?","name":"articletitle","label":"Article Title"},{"value":"Vascular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vph.2016.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.vph.2016.04.005","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}